Search CORE

4 research outputs found

Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers

Author: Bonneville R
Cheah PL
KEYTRUDA®
O’Malley D
Pan ZK
Publication venue: 'Future Science Ltd'
Publication date
Field of study

Treatment patterns of malignant melanoma in the United States from 2011 to 2016: a retrospective cohort study

Author: Arondekar B
Avastin® (Bevacizumab
BRAFTOVITM (encorafenib
COTELLIC® (cobimetinib)
David Cohan
KEYTRUDA® (pembrolizumab)
Leon Raskin
MEKINIST® (trametinib)
MEKTOVITM (binimetinib
Morganna Freeman
Omid Hamid
Opdivo® (nivolumab
Shweta Shah
TAFINLAR® (dabrafenib).
Yervoy® (ipilimumab
ZELBORAF® (vemurafenib
Publication venue: 'Informa UK Limited'
Publication date
Field of study

Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer

Author: Adebayo Ogunniyi
Alexander Drilon
Brahmer JR
Goldberg SB
Meagan S Barbee
Mok T
Papadimitrakopoulou V
Patnaik A
Pembrolizumab (Keytruda®)
Rizvi NA
Thu Oanh Dang
Publication venue: 'Informa UK Limited'
Publication date
Field of study

A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer

Author: A Bacic
A Jonas
A Jonas
AS Chan
ASH Chan
ASH Chan
Avastin® (bevacizumab) Prescribing Information
B Besse
B Li
B Li
C Halstenson
C Qi
C Salvador
CG Azzoli
F. Schneller
G Cornelio
J. F. Marier
J. Kollmeier
J. Lowe
J. R. Trout
K Fraser
K Fraser
K. Gorden
Keytruda® (pembrolizumab) Prescribing Information
M. Beliveau
M. Gargano
M. L. Patchen
M. Thomas
MB Tamayo
MB Tamayo
N Bose
N Bose
N. Bose
P. Mattson
P. Sadjadian
PM Kidd
R Pirker
R. Walsh
RB Fulton
SM Leonardo
SM Leonardo
Tecentriq® (atezolizumab) Prescribing Information
TJ Lynch
TT Chen
W Zhong
WS Engel-Riedel
Z Zhou
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

core

core